Migraine as a Risk Factor for Peripheral Artery Occlusive Disease: A Population-Based Cohort Study.

International Journal of Environmental Research and Public Health
Fu-Hsuan KuoShun-Fa Yang

Abstract

We aim to evaluate the development of peripheral occlusive artery disease (PAOD) in patients with migraine by using the National Health Insurance Research Database in Taiwan. A retrospective cohort study was conducted and individuals with diagnostic codes of migraine were enrolled in the study group after excluding those diagnosed with PAOD before the index date. Each subject with migraine was propensity-score matched to another non-migraine patient and the latter served as the control group. A total of 37,288 patients were finally enrolled in the groups. The primary outcome was set as the development of PAOD between the two groups while multiple possible risk factors, including demographic data and comorbidities, were analyzed via the Cox proportional hazards regression. There were 885 and 530 PAOD events in the study and control groups, and the study group had a significantly higher adjusted hazard ratio (1.65, 95% confidential interval: 1.48-1.84, p < 0.001), and the cumulative incidence also revealed a correlation between migraine and PAOD. Other potential risk factors related to the existence of PAOD include age, hypertension, chronic kidney disease, diabetes mellitus, coronary artery disease, stroke, and asthma. For indiv...Continue Reading

References

Mar 1, 1995·European Journal of Clinical Investigation·M Van den BergC D Stehouwert
Oct 25, 2001·Lancet·K Ouriel
Jan 30, 2004·JAMA : the Journal of the American Medical Association·Mark C KruitLenore J Launer
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Dec 25, 2008·Circulation·Mark A CreagerUNKNOWN American Heart Association
Feb 12, 2010·Neurology·M E BigalR B Lipton
May 25, 2010·The American Journal of Medicine·June T SpectorSaman Nazarian
Dec 17, 2011·Lancet Neurology·Tobias KurthMarie-Germaine Bousser
Oct 25, 2012·JAMA : the Journal of the American Medical Association·Michel M JoostenKenneth J Mukamal
May 3, 2013·BMC Medicine·Johan Frostegård
Oct 3, 2013·The Journal of Headache and Pain·Simona SaccoTobias Kurth
Apr 25, 2015·Circulation Research·Michael H Criqui, Victor Aboyans
Apr 28, 2016·Cephalalgia : an International Journal of Headache·Kuan-Po PengShuu-Jiun Wang
Jun 2, 2016·BMJ : British Medical Journal·Tobias KurthKathryn M Rexrode
Jul 19, 2017·The Lancet. Diabetes & Endocrinology·Kunihiro MatsushitaUNKNOWN Chronic Kidney Disease Prognosis Consortium
Oct 4, 2017·Brain : a Journal of Neurology·Maria LantzKarin Wirdefeldt
Feb 2, 2018·BMJ : British Medical Journal·Kasper AdelborgHenrik Toft Sørensen
Feb 9, 2018·BMJ : British Medical Journal·Rachael L MorleyRobert J Hinchliffe
Mar 11, 2018·Lancet·David W Dodick
Jan 16, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Aynur Yilmaz AvciMustafa Agah Tekindal
Jun 1, 2019·The American Journal of Medicine·Umberto CampiaSamuel Z Goldhaber
Oct 5, 2019·Nucleic Acids Research·Yang GaoShuhua Xu

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.